Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	TRIO MYCBP2 ARHGEF11 ECT2 DIS3 PREX2 DENND3 PREX1	3.02e-05	231	105	8	GO:0005085
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RGPD8 TRIO MYCBP2 RGPD1 ARHGEF11 ECT2 DIS3 PREX2 DENND3 PREX1 RGPD5	7.36e-05	507	105	11	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RGPD8 TRIO MYCBP2 RGPD1 ARHGEF11 ECT2 DIS3 PREX2 DENND3 PREX1 RGPD5	7.36e-05	507	105	11	GO:0030695
GeneOntologyMolecularFunction	glutamate receptor activity	GRID1 GRID2 GRIN2B	3.77e-04	27	105	3	GO:0008066
GeneOntologyCellularComponent	postsynaptic membrane	SEMA4F ERBB3 NAPEPLD SYNE1 GRID1 GRID2 GRIN2B SLC6A6 STRN UTRN	4.06e-05	405	106	10	GO:0045211
GeneOntologyCellularComponent	cis-Golgi network	HLA-A GOLGA8R GOLGA8N ATP2C1 GOLGA8O	7.25e-05	85	106	5	GO:0005801
GeneOntologyCellularComponent	synaptic membrane	SEMA4F ERBB3 NAPEPLD SYNE1 GRID1 GRID2 GRIN2B CNTN6 SLC6A6 STRN UTRN	1.83e-04	583	106	11	GO:0097060
GeneOntologyCellularComponent	Golgi cis cisterna	GOLGA8R GOLGA8N GOLGA8O	6.19e-04	33	106	3	GO:0000137
GeneOntologyCellularComponent	Golgi cisterna	HLA-A GOLGA8R GOLGA8N ATP2C1 GOLGA8O	6.27e-04	135	106	5	GO:0031985
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RGPD8 RGPD1	6.99e-04	8	106	2	GO:1990723
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RGPD8 RGPD1	1.12e-03	10	106	2	GO:0044614
GeneOntologyCellularComponent	Golgi cisterna membrane	GOLGA8R GOLGA8N ATP2C1 GOLGA8O	1.34e-03	94	106	4	GO:0032580
GeneOntologyCellularComponent	parallel fiber to Purkinje cell synapse	GRID2 GRIN2B CNTN6	1.35e-03	43	106	3	GO:0098688
Domain	GDS_CDC24_CS	TRIO ARHGEF11 ECT2 PREX2 PREX1	2.64e-06	39	106	5	IPR001331
Domain	Grip	RGPD8 RGPD1 RGPD5	2.84e-05	11	106	3	SM00755
Domain	GRIP	RGPD8 RGPD1 RGPD5	2.84e-05	11	106	3	PF01465
Domain	DH_1	TRIO ARHGEF11 ECT2 PREX2 PREX1	2.90e-05	63	106	5	PS00741
Domain	PH_dom-like	RGPD8 TRIO PLEKHF2 RGPD1 ARHGEF11 ECT2 CERT1 PREX2 OSBP PREX1 RGPD5	3.04e-05	426	106	11	IPR011993
Domain	RRP44_S1	DIS3L DIS3	3.19e-05	2	106	2	IPR033770
Domain	Rrp44_S1	DIS3L DIS3	3.19e-05	2	106	2	PF17215
Domain	Ran_BP1	RGPD8 RGPD1 RGPD5	3.77e-05	12	106	3	PF00638
Domain	GRIP_dom	RGPD8 RGPD1 RGPD5	3.77e-05	12	106	3	IPR000237
Domain	GRIP	RGPD8 RGPD1 RGPD5	3.77e-05	12	106	3	PS50913
Domain	RANBD1	RGPD8 RGPD1 RGPD5	3.77e-05	12	106	3	PS50196
Domain	-	ZYG11A ARMC3 TOGARAM2 CKAP5 CHIC1 TRRAP XPO5 PDS5A	3.90e-05	222	106	8	1.25.10.10
Domain	RhoGEF	TRIO ARHGEF11 ECT2 PREX2 PREX1	4.20e-05	68	106	5	SM00325
Domain	RhoGEF	TRIO ARHGEF11 ECT2 PREX2 PREX1	4.83e-05	70	106	5	PF00621
Domain	DH_2	TRIO ARHGEF11 ECT2 PREX2 PREX1	4.83e-05	70	106	5	PS50010
Domain	RanBD	RGPD8 RGPD1 RGPD5	4.88e-05	13	106	3	SM00160
Domain	Ran_bind_dom	RGPD8 RGPD1 RGPD5	4.88e-05	13	106	3	IPR000156
Domain	DH-domain	TRIO ARHGEF11 ECT2 PREX2 PREX1	5.18e-05	71	106	5	IPR000219
Domain	-	TRIO ARHGEF11 ECT2 PREX2 PREX1	5.18e-05	71	106	5	1.20.900.10
Domain	-	RGPD8 TRIO PLEKHF2 RGPD1 ARHGEF11 ECT2 CERT1 PREX2 OSBP PREX1	7.70e-05	391	106	10	2.30.29.30
Domain	ZF_BBOX	TRIM49 MYCBP2 TRIM49C TRIM67 TRIM49B	9.18e-05	80	106	5	PS50119
Domain	Rrp44_CSD1	DIS3L DIS3	9.54e-05	3	106	2	IPR033771
Domain	RIBONUCLEASE_II	DIS3L DIS3	9.54e-05	3	106	2	PS01175
Domain	Rrp44_CSD1	DIS3L DIS3	9.54e-05	3	106	2	PF17216
Domain	Znf_B-box	TRIM49 MYCBP2 TRIM49C TRIM67 TRIM49B	9.74e-05	81	106	5	IPR000315
Domain	Iontro_rcpt	GRID1 GRID2 GRIN2B	1.36e-04	18	106	3	IPR001320
Domain	Lig_chan-Glu_bd	GRID1 GRID2 GRIN2B	1.36e-04	18	106	3	PF10613
Domain	GOLGA2L5	GOLGA8R GOLGA8N GOLGA8O	1.36e-04	18	106	3	PF15070
Domain	Golgin_A	GOLGA8R GOLGA8N GOLGA8O	1.36e-04	18	106	3	IPR024858
Domain	Iono_rcpt_met	GRID1 GRID2 GRIN2B	1.36e-04	18	106	3	IPR001508
Domain	Glu/Gly-bd	GRID1 GRID2 GRIN2B	1.36e-04	18	106	3	IPR019594
Domain	Lig_chan-Glu_bd	GRID1 GRID2 GRIN2B	1.36e-04	18	106	3	SM00918
Domain	Lig_chan	GRID1 GRID2 GRIN2B	1.36e-04	18	106	3	PF00060
Domain	PBPe	GRID1 GRID2 GRIN2B	1.36e-04	18	106	3	SM00079
Domain	ARM-like	ZYG11A ARMC3 TOGARAM2 CKAP5 CHIC1 TRRAP XPO5 PDS5A	1.53e-04	270	106	8	IPR011989
Domain	PH	TRIO PLEKHF2 ARHGEF11 ECT2 CERT1 PREX2 OSBP PREX1	1.86e-04	278	106	8	SM00233
Domain	RNase_II/R_CS	DIS3L DIS3	1.90e-04	4	106	2	IPR022966
Domain	CLASP_N	TOGARAM2 CKAP5	1.90e-04	4	106	2	PF12348
Domain	CLASP_N_dom	TOGARAM2 CKAP5	1.90e-04	4	106	2	IPR024395
Domain	PH_DOMAIN	TRIO PLEKHF2 ARHGEF11 ECT2 CERT1 PREX2 OSBP PREX1	1.91e-04	279	106	8	PS50003
Domain	PH_domain	TRIO PLEKHF2 ARHGEF11 ECT2 CERT1 PREX2 OSBP PREX1	1.96e-04	280	106	8	IPR001849
Domain	Spectrin	TRIO SYNE1 UTRN	2.90e-04	23	106	3	PF00435
Domain	-	TDRD15 RNF17	4.72e-04	6	106	2	2.40.50.90
Domain	Staphylococal_nuclease_OB-fold	TDRD15 RNF17	4.72e-04	6	106	2	IPR016071
Domain	IG_LIKE	HLA-A TRIO KIR2DS2 CNTN6 IGSF10 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.81e-04	491	106	10	PS50835
Domain	Ig-like_dom	HLA-A TRIO KIR2DS2 CNTN6 IGSF10 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	5.80e-04	503	106	10	IPR007110
Domain	Spectrin_repeat	TRIO SYNE1 UTRN	5.83e-04	29	106	3	IPR002017
Domain	BBOX	TRIM49 TRIM49C TRIM67 TRIM49B	6.38e-04	69	106	4	SM00336
Domain	GCC2_Rab_bind	RGPD8 RGPD1	6.58e-04	7	106	2	IPR032023
Domain	APC_su10/DOC_dom	MYCBP2 HECTD3	6.58e-04	7	106	2	IPR004939
Domain	DOC	MYCBP2 HECTD3	6.58e-04	7	106	2	PS51284
Domain	Rab_bind	RGPD8 RGPD1	6.58e-04	7	106	2	PF16704
Domain	APC10	MYCBP2 HECTD3	6.58e-04	7	106	2	SM01337
Domain	ANAPC10	MYCBP2 HECTD3	6.58e-04	7	106	2	PF03256
Domain	IG	TRIO KIR2DS2 CNTN6 IGSF10 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	6.59e-04	421	106	9	SM00409
Domain	Ig_sub	TRIO KIR2DS2 CNTN6 IGSF10 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	6.59e-04	421	106	9	IPR003599
Domain	Ig-like_fold	HLA-A TRIO MYCBP2 KIR2DS2 CNTN6 IGSF10 TRIM67 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	6.62e-04	706	106	12	IPR013783
Domain	-	TRIM49 TRIM49C TRIM67 TRIM49B	7.11e-04	71	106	4	4.10.45.10
Domain	zf-B_box	TRIM49 TRIM49C TRIM67 TRIM49B	7.50e-04	72	106	4	PF00643
Domain	ig	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.53e-04	190	106	6	PF00047
Domain	Immunoglobulin	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.53e-04	190	106	6	IPR013151
Domain	Spectrin/alpha-actinin	TRIO SYNE1 UTRN	7.82e-04	32	106	3	IPR018159
Domain	SPEC	TRIO SYNE1 UTRN	7.82e-04	32	106	3	SM00150
Domain	ANF_lig-bd_rcpt	GRID1 GRID2 GRIN2B	1.20e-03	37	106	3	IPR001828
Domain	ANF_receptor	GRID1 GRID2 GRIN2B	1.20e-03	37	106	3	PF01094
Domain	-	HLA-A TRIO MYCBP2 KIR2DS2 CNTN6 IGSF10 TRIM67 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1	1.36e-03	663	106	11	2.60.40.10
Domain	-	RGPD8 RGPD1	1.39e-03	10	106	2	1.10.220.60
Domain	Peripla_BP_I	GRID1 GRID2 GRIN2B	1.40e-03	39	106	3	IPR028082
Domain	SPRY	TRIM49 TRIM49C TRIM67 TRIM49B	1.52e-03	87	106	4	SM00449
Domain	PH	TRIO PLEKHF2 CERT1 PREX2 OSBP PREX1	1.96e-03	229	106	6	PF00169
Domain	SPRY	TRIM49 TRIM49C TRIM67 TRIM49B	2.02e-03	94	106	4	PF00622
Domain	SPRY_dom	TRIM49 TRIM49C TRIM67 TRIM49B	2.02e-03	94	106	4	IPR003877
Domain	B30.2/SPRY	TRIM49 TRIM49C TRIM67 TRIM49B	2.10e-03	95	106	4	IPR001870
Domain	B302_SPRY	TRIM49 TRIM49C TRIM67 TRIM49B	2.10e-03	95	106	4	PS50188
Domain	TUDOR	TDRD15 RNF17	2.78e-03	14	106	2	PF00567
Domain	ARM-type_fold	ZYG11A ARMC3 TOGARAM2 CKAP5 TRRAP XPO5 PDS5A	3.21e-03	339	106	7	IPR016024
Domain	BRCT	ECT2 PARP4	5.12e-03	19	106	2	PF00533
Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	HLA-A KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1 HSPA6	3.72e-07	88	74	7	M16004
Pathway	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	HLA-A KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	8.13e-05	137	74	6	M5669
Pathway	REACTOME_DAP12_INTERACTIONS	KIR2DS2 KIR2DS1 KIR2DS4 KIR2DS5	9.66e-05	46	74	4	M27151
Pathway	PID_RHOA_REG_PATHWAY	CDKN1B TRIO ARHGEF11 ECT2	9.66e-05	46	74	4	M68
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	SEMA4F RGPD8 TRIO RGPD1 CKAP5 ARHGEF11 ECT2 PREX2 GOLGA8N ZNF512B GOLGA8O PREX1	1.31e-04	649	74	12	MM15690
Pathway	REACTOME_CDC42_GTPASE_CYCLE	TRIO ARHGEF11 ECT2 PREX2 PREX1	1.33e-04	94	74	5	MM15598
Pathway	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	TRIO ARHGEF11 ECT2 PREX1	1.57e-04	52	74	4	MM14743
Pathway	REACTOME_CDC42_GTPASE_CYCLE	TRIO GOLGA8R ARHGEF11 ECT2 PREX2 PREX1	1.60e-04	155	74	6	M41808
Pathway	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	TRIO ARHGEF11 ECT2 PREX1	2.56e-04	59	74	4	M11215
Pathway	REACTOME_RHO_GTPASE_CYCLE	SEMA4F TRIO ARHGEF11 ECT2 PREX2 GOLGA8N ZNF512B GOLGA8O PREX1	4.66e-04	439	74	9	MM15595
Pathway	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	TRIO ARHGEF11 ECT2 PREX1	4.94e-04	70	74	4	MM14824
Pathway	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	TRIO ARHGEF11 ECT2 PREX1	6.75e-04	76	74	4	M19832
Pathway	REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS	TRIO ARHGEF11 ECT2 PREX1	7.09e-04	77	74	4	MM15044
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.70e-15	13	111	7	19934297
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.75e-14	15	111	7	19850842
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.75e-14	15	111	7	19493232
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	3.11e-14	16	111	7	20331834
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	5.27e-14	17	111	7	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	5.27e-14	17	111	7	20483367
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	5.27e-14	17	111	7	19968064
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1	7.68e-14	9	111	6	18340360
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	8.60e-14	18	111	7	19630074
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	8.60e-14	18	111	7	20519398
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.36e-13	19	111	7	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.36e-13	19	111	7	18778326
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.36e-13	19	111	7	20600442
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.36e-13	19	111	7	18848853
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	2.09e-13	20	111	7	20193031
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	2.09e-13	20	111	7	20426625
Pubmed	In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.02e-13	5	111	5	19410616
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	3.12e-13	21	111	7	19861144
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.20e-13	11	111	6	19664392
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.56e-13	22	111	7	20492596
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	8.38e-13	12	111	6	20371502
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	8.38e-13	12	111	6	19181658
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	8.38e-13	12	111	6	20137308
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	8.38e-13	12	111	6	19936734
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.55e-12	13	111	6	18687225
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.55e-12	13	111	6	19120281
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	2.71e-12	14	111	6	19875891
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	2.71e-12	14	111	6	19421224
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	2.71e-12	14	111	6	15896204
Pubmed	Immunogenetic characteristics of patients with autoimmune gastritis.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.10e-12	29	111	7	20082482
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.51e-12	15	111	6	20082646
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.51e-12	15	111	6	19926642
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.51e-12	15	111	6	20207982
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.51e-12	15	111	6	20356536
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.51e-12	15	111	6	20643584
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.51e-12	15	111	6	17498266
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.51e-12	15	111	6	19326408
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	20670355
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	20652381
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	18668235
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	18643961
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	19309280
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	16403292
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.19e-12	16	111	6	20210919
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.11e-11	17	111	6	20173784
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.11e-11	17	111	6	19218127
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.11e-11	17	111	6	19169284
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.11e-11	17	111	6	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.11e-11	17	111	6	20650299
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.11e-11	17	111	6	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.11e-11	17	111	6	19761533
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.66e-11	18	111	6	20200544
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.66e-11	18	111	6	19046302
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.66e-11	18	111	6	19846535
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.66e-11	18	111	6	20580654
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	HLA-A KIR2DS2 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.66e-11	18	111	6	20210918
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.68e-11	8	111	5	18681957
Pubmed	Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.	HLA-A KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.74e-11	35	111	7	19683555
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS2 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	3.77e-11	9	111	5	7749980
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS2 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	3.77e-11	9	111	5	8662091
Pubmed	Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.	KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	7.52e-11	10	111	5	21206914
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL1	7.52e-11	10	111	5	12559621
Pubmed	Natural killer cells and immune surveillance.	KIR2DS2 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.38e-10	11	111	5	18830515
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR3DL1	5.92e-10	14	111	5	19489269
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR2DS2 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1	5.92e-10	14	111	5	18945962
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.	KIR2DS2 KIR2DS1 KIR2DS3 KIR3DL1	1.47e-09	6	111	4	20528243
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.81e-09	17	111	5	19032228
Pubmed	Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.	KIR2DS2 KIR2DS4 KIR2DS5 KIR3DL1	3.41e-09	7	111	4	14607943
Pubmed	A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.	KIR2DS3 KIR2DS4 KIR2DS5	3.16e-08	3	111	3	8765026
Pubmed	Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.	KIR2DS1 KIR2DS3 KIR2DS5	3.16e-08	3	111	3	19500138
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR2DS2 KIR2DS4 KIR2DS5 KIR3DL1	4.77e-08	12	111	4	17490516
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SEMA4F TOPAZ1 CKAP5 ECT2 IGSF10 SLC6A6 PARP4 SAMD9L MDN1 SLC22A16 AGL PDS5A UTRN BANK1	1.01e-07	736	111	14	29676528
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NR2C2 TSHZ3 RGPD8 MYCBP2 RGPD1 CKAP5 IKBKG POGZ UTRN HSPA6 KNL1	1.07e-07	418	111	11	34709266
Pubmed	A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis.	KIR2DS1 KIR2DS3 KIR2DS5	1.26e-07	4	111	3	16829306
Pubmed	Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.	KIR2DS2 KIR2DS1 KIR2DS4	3.15e-07	5	111	3	10424431
Pubmed	Identification of a genomic reservoir for new TRIM genes in primate genomes.	TRIM49 TRIM49C TRIM49B TRIM51G	3.67e-07	19	111	4	22144910
Pubmed	Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.	KIR2DS2 KIR2DS1 KIR2DS3	6.28e-07	6	111	3	17882223
Pubmed	Complex genomic rearrangements lead to novel primate gene function.	RGPD8 RGPD1 RGPD5	1.10e-06	7	111	3	15710750
Pubmed	Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.	KIR2DS2 KIR2DS1 KIR2DS4	1.10e-06	7	111	3	11169255
Pubmed	Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.	KIR2DS1 KIR2DS3 KIR3DL1	1.10e-06	7	111	3	9430220
Pubmed	KIR haplotype content at the allele level in 77 Northern Irish families.	KIR2DS2 KIR2DS4 KIR3DL1	1.75e-06	8	111	3	17200871
Pubmed	Human diversity in killer cell inhibitory receptor genes.	KIR2DS1 KIR2DS3 KIR3DL1	1.75e-06	8	111	3	9430221
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF21B RGPD8 TRIO MYCBP2 SYNE1 RGPD1 CKAP5 GRIN2B ARHGEF11 GOLGA8N STRN MDN1 TRIM67 GOLGA8O	2.47e-06	963	111	14	28671696
Pubmed	Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.	KIR2DS2 KIR2DS1 KIR2DS3	2.62e-06	9	111	3	18074414
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	TRIO MYCBP2 HECTD3 IKBKG TRRAP STRN PDS5A	5.62e-06	212	111	7	33853758
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	RGPD8 RGPD1 CKAP5 DIS3 STRN UTRN RGPD5	6.17e-06	215	111	7	35973513
Pubmed	Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein.	CERT1 OSBP	1.01e-05	2	111	2	21285358
Pubmed	Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5.	KIR2DS1 KIR2DS5	1.01e-05	2	111	2	18682925
Pubmed	Association of KIR gene polymorphisms with COVID-19 disease.	KIR2DS4 KIR3DL1	1.01e-05	2	111	2	34929414
Pubmed	Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation.	KIR2DS2 KIR2DS1	1.01e-05	2	111	2	16504727
Pubmed	Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.	HLA-A KIR3DL1	1.01e-05	2	111	2	19752231
Pubmed	Novel insights in the genomic organization and hotspots of recombination in the human KIR locus through analysis of intergenic regions.	KIR2DS4 KIR3DL1	1.01e-05	2	111	2	25503311
Pubmed	The presence of KIR2DS5 confers protection against adult immune thrombocytopenia.	KIR2DS2 KIR2DS5	1.01e-05	2	111	2	24571473
Pubmed	P-Rex1 and P-Rex2 RacGEFs and cancer.	PREX2 PREX1	1.01e-05	2	111	2	28710285
Pubmed	Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.	HLA-A KIR3DL1	1.01e-05	2	111	2	17182537
Interaction	KIR2DS2 interactions	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL1	1.40e-06	37	106	5	int:KIR2DS2
Interaction	RAN interactions	NR2C2 RGPD8 MYCBP2 RGPD1 IKBKG DIS3 IGSF10 TRIM67 XPO5 AGL HSPA6 RGPD5	7.58e-06	475	106	12	int:RAN
Cytoband	19q13.4	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	4.20e-08	79	111	6	19q13.4
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	8.72e-11	18	77	6	620
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO ARHGEF11 ECT2 PREX2 PREX1	8.96e-06	66	77	5	722
GeneFamily	Glutamate ionotropic receptor delta type subunits	GRID1 GRID2	1.79e-05	2	77	2	1202
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM49 TRIM49C TRIM67 TRIM49B TRIM51G	5.28e-05	95	77	5	59
GeneFamily	Exosome complex	DIS3L DIS3	1.15e-03	12	77	2	817
GeneFamily	WD repeat domain containing\|Protein phosphatase 2 regulatory subunits	PPP2R3B STRN	1.81e-03	15	77	2	696
GeneFamily	Synaptotagmins	SYT16 SYT14	2.34e-03	17	77	2	765
GeneFamily	WD repeat domain containing	KIF21B DCAF4L2 DENND3 STRN WDHD1	5.20e-03	262	77	5	362
GeneFamily	Ring finger proteins	TRIM49 TRIM49C RNF17 TRIM67 TRIM49B	6.36e-03	275	77	5	58
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	KIR2DS2 CDCP1 KIR2DS1 KIR2DS4 KIR2DS5 KIR3DL1	6.66e-03	394	77	6	471
Coexpression	KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS5 KIR3DL1	1.79e-06	49	108	5	M40909
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	KIF21B SYNE1 GOLGA8R SAMD9L KIR3DL1 GOLGA8O UTRN	5.53e-07	200	107	7	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	IQANK1 ARMC3 TOGARAM2 CCDC81 LGSN LRRIQ1	5.03e-06	181	107	6	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYCBP2 PREX2 SLC6A6 KLHL5 UTRN BANK1	6.65e-06	190	107	6	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERBB3 GRIN2B CERT1 CNTN6 ADGRG6 PREX1	7.27e-06	193	107	6	3ea6b103e35bbb276e95301999618558fa3e38b1
ToppCell	COVID_non-vent-Lymphocytic-ILC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SYNE1 GOLGA8R GOLGA8N KIR3DL1 GOLGA8O UTRN	8.66e-06	199	107	6	df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCell	COVID_vent-Lymphocytic-ILC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SYNE1 GOLGA8R GOLGA8N KIR3DL1 GOLGA8O UTRN	8.66e-06	199	107	6	e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a
ToppCell	COVID_non-vent-Lymphocytic-ILC-NK_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SYNE1 GOLGA8R GOLGA8N KIR3DL1 GOLGA8O UTRN	8.66e-06	199	107	6	ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCell	COVID_vent-Lymphocytic-ILC-NK_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SYNE1 GOLGA8R GOLGA8N KIR3DL1 GOLGA8O UTRN	8.66e-06	199	107	6	5f914962e2572b0c6372465b81b7496fa663d93c
ToppCell	TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3\|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9	ARMT1 TRIO SYNE1 CERT1 PPIP5K2	1.88e-05	135	107	5	ac20133d4a36f48338b45bffb13e842cb66f83ad
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 TOGARAM2 CCDC81 LRRIQ1 SLC22A16	3.53e-05	154	107	5	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARMC3 TOGARAM2 CCDC81 LRRIQ1 SLC22A16	3.53e-05	154	107	5	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CCDC81 ZNF512B PARP4 SAMD9L MDN1	4.63e-05	163	107	5	130c84bca3f72ab7d1a4fee2990c3d01600318ed
ToppCell	Control-T/NK_proliferative\|World / Disease group and Cell class	ZNF268 PPP2R3B CDCP1 XPO5 KNL1	5.50e-05	169	107	5	fca735cbb55fce4d32dc6632a39acea1d16b87ab
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 PREX2 SAMD9L ELK4 UTRN	7.03e-05	178	107	5	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ARMC3 TOGARAM2 CCDC81 LGSN LRRIQ1	7.03e-05	178	107	5	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 PREX2 DENND3 IGSF10 ABCC8	7.41e-05	180	107	5	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 PREX2 DENND3 IGSF10 ABCC8	7.41e-05	180	107	5	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PREX2 DENND3 ADGRG6 SLC6A6 UTRN	7.61e-05	181	107	5	4d7793026373cbcf04b15c77f95f1025d07d4c00
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1B MYCBP2 SAMD9L ELK4 BANK1	7.81e-05	182	107	5	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PREX2 DENND3 ADGRG6 SLC6A6 UTRN	8.01e-05	183	107	5	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSHZ3 GRID2 KLHL5 TRIM49B UTRN	8.43e-05	185	107	5	ae53aa2ecfe418a5dbd7d963a995bc06dab94f56
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERBB3 GRID2 CERT1 CNTN6 ADGRG6	8.43e-05	185	107	5	dd17025d8c423aa0a451ac7f1f301c93528e0229
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells-Pro-B\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PPP2R3B CCDC81 DENND3 SLC22A16 BANK1	8.65e-05	186	107	5	4a5264e32ba004ed58dc4102d84e4bc4dbbe1440
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CERT1 PREX2 SAMD9L ELK4 UTRN	8.65e-05	186	107	5	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PPP2R3B CCDC81 DENND3 SLC22A16 BANK1	8.65e-05	186	107	5	528ee88f6e27863c7bcdffd4416cbbd83fc65e9d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO SYNE1 PARP4 STRN UTRN	9.09e-05	188	107	5	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARMC3 ECT2 LRRIQ1 IQCC KNL1	9.56e-05	190	107	5	da60bcc4b59d8e3719d8201387d567594059b1a4
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARMC3 ECT2 LRRIQ1 IQCC KNL1	9.56e-05	190	107	5	827a1f4e4ac4beada262f4fb965dd74a447a8f4f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSHZ3 ADGRG6 KLHL5 TRIM67 UTRN	1.00e-04	192	107	5	dc40ef2341e5d6a6d479f140e023fe1bf687928d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSHZ3 GRID2 ADGRG6 KLHL5 TRIM67	1.03e-04	193	107	5	d1445b8bf2bab36e1a326ddb2a528151db016c7d
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1\|TCGA-Endometrium / Sample_Type by Project: Shred V9	CKAP5 SLC6A6 WDHD1 PDS5A KNL1	1.03e-04	193	107	5	c2673d86f7d7b849788036032a93a6d136a70040
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSHZ3 GRID2 PREX2 KLHL5 TRIM67	1.03e-04	193	107	5	8b77625bf3c87d39767fb391d1beaca4ab02342b
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSHZ3 GRID2 ADGRG6 KLHL5 TRIM67	1.03e-04	193	107	5	3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b
ToppCell	IPF-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	HLA-A SYNE1 KLHL5 SAMD9L PREX1	1.05e-04	194	107	5	777ce41c3f22c591e2d81120f189b834e53ffb4b
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSHZ3 GRID2 ADGRG6 KLHL5 TRIM67	1.05e-04	194	107	5	1bcb3fafd498614f7bac2b1c9b7de56e39110f65
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-A SYNE1 KIR2DS4 KIR3DL1 UTRN	1.05e-04	194	107	5	ae5357e2a276473cde1fc8c43acaf9f69da35fd7
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-A SYNE1 KIR2DS4 KIR3DL1 UTRN	1.05e-04	194	107	5	3a0b8b5d0354c43da57bb951cd8ba878363c3de5
ToppCell	mild-B_cell\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZYG11A POGZ DIS3 IQCC BANK1	1.08e-04	195	107	5	1e5f1967bcc898318f4e970b844b4a944eb168e5
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	CKAP5 ECT2 WDHD1 SLC22A16 KNL1	1.08e-04	195	107	5	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	HLA-A SYNE1 PREX2 KLHL5 UTRN	1.08e-04	195	107	5	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARMC3 SYNE1 TOGARAM2 CCDC81 LRRIQ1	1.11e-04	196	107	5	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	(05)_Ciliated\|World / shred by cell type and Timepoint	ARMC3 SYNE1 TOGARAM2 FBXO36 CCDC81	1.13e-04	197	107	5	fee3cd16af8eea697cd64e8f64af505aaa2ac4b0
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNE1 TOGARAM2 CCDC81 LGSN LRRIQ1	1.13e-04	197	107	5	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	COVID-19_Severe-NK_activated\|World / disease group, cell group and cell class	HLA-A SYNE1 SAMD9L KIR3DL1 UTRN	1.13e-04	197	107	5	a60db36d1a192998e3ded63e0c7c08d41689f95f
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	HLA-A SYNE1 PREX2 KLHL5 UTRN	1.13e-04	197	107	5	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HLA-A SYNE1 GOLGA8R GOLGA8N UTRN	1.16e-04	198	107	5	d7053a898e04478c577381085f615edaad3cdc5b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 PREX2 KLHL5 UTRN PREX1	1.16e-04	198	107	5	451003a21162eeae90739fdb502bb50b362d80c8
ToppCell	healthy_donor-Lymphocytic-ILC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HLA-A SYNE1 GOLGA8R GOLGA8N UTRN	1.16e-04	198	107	5	aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 PREX2 KLHL5 UTRN PREX1	1.16e-04	198	107	5	440af8f90c7afa1c07000806bcf9110b70f489fb
ToppCell	COVID-19_Moderate-NK\|World / disease group, cell group and cell class	HLA-A SYNE1 TOGARAM2 KIR3DL1 UTRN	1.19e-04	199	107	5	c41b67b760831c7d5e19fabcc932a056dc560f93
Drug	D-Au	HLA-A KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	1.60e-06	77	106	6	CID000277822
Drug	Aa1	SYNE1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 KIR3DL1	2.49e-06	83	106	6	CID009549188
Drug	p-terphenyl	CDKN1B TRIO SYNE1 SLC22A16 AGL KIR3DL1	8.76e-06	103	106	6	CID000007115
Disease	blood pressure	SYNE1 PREX1 BANK1	5.72e-05	22	101	3	EFO_0004325
Disease	Insulinogenic index measurement	MYCBP2 PPIP5K2	1.15e-04	5	101	2	EFO_0009961
Disease	Neurodevelopmental Disorders	TRIO POGZ GRIN2B CERT1	2.99e-04	93	101	4	C1535926
Disease	ribose-5-phosphate measurement, ribulose-5-phosphate measurement	ACOT9 GRID2	3.20e-04	8	101	2	EFO_0010529, EFO_0010530
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	TDRD15 HLA-A CERT1 BANK1	8.08e-04	121	101	4	EFO_0008595, EFO_0020943
Disease	Intellectual Disability	TRIO ACOT9 SYNE1 POGZ GRIN2B CERT1 TRRAP	8.84e-04	447	101	7	C3714756
Disease	transitional cell carcinoma (is_marker_for)	CDKN1B ERBB3 XPO5	1.33e-03	63	101	3	DOID:2671 (is_marker_for)
Disease	idiopathic scoliosis (implicated_via_orthology)	PPP2R3B ADGRG6	1.35e-03	16	101	2	DOID:0060250 (implicated_via_orthology)
Disease	cognitive function measurement, self reported educational attainment	MYCBP2 PEF1 PPA2 PREX1 BANK1 KNL1	1.41e-03	355	101	6	EFO_0004784, EFO_0008354
Disease	lymphocyte count	CDKN1B ERBB3 HLA-A ARHGEF11 PREX2 DENND3 PPA2 ELK4 PPIP5K2 KIR2DS4 PREX1 HSPA6 KNL1	1.47e-03	1464	101	13	EFO_0004587
Disease	selenium measurement, response to dietary selenium supplementation	TRIO CNTN6	2.12e-03	20	101	2	EFO_0006331, EFO_0600021
Disease	attention deficit hyperactivity disorder, autism spectrum disorder, intelligence	TSHZ3 GRID2 PEF1 PPA2 PREX1 BANK1	2.51e-03	398	101	6	EFO_0003756, EFO_0003888, EFO_0004337
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	TDRD15 HLA-A ECT2 SYT14 ANXA10	2.55e-03	274	101	5	EFO_0004530, EFO_0004612
Disease	cholangiocarcinoma (is_implicated_in)	PREX2 WDHD1	2.56e-03	22	101	2	DOID:4947 (is_implicated_in)
Disease	Nasopharyngeal carcinoma	ERBB3 SYNE1	2.56e-03	22	101	2	C2931822
Disease	hip bone mineral density, fat body mass	DCAF4L2 GRID1	2.56e-03	22	101	2	EFO_0005409, EFO_0007702
Disease	response to selective serotonin reuptake inhibitor	TSHZ3 GRIN2B PREX1	2.83e-03	82	101	3	EFO_0005658
Disease	brain measurement, neuroimaging measurement	KIF21B ERBB3 RGPD1 DENND3 STRN LRRIQ1 MAEL	2.87e-03	550	101	7	EFO_0004346, EFO_0004464
Disease	response to anticonvulsant	TDRD15 HLA-A PREX2	3.14e-03	85	101	3	GO_0036277

Protein segments in the cluster

Peptide	Gene	Start	Entry
HLLQCSGATWASKMK	BANK1	361	Q8NDB2
MEHLWSLLSNCKKTR	ARMT1	226	Q9H993
IEQVKHSNHKWMSKC	ARMT1	301	Q9H993
KNDKLCHMDTIDWRD	ERBB3	151	P21860
WEACQQKTGEHKTML	ANXA10	181	Q9UJ72
RLWMNVEKTISCTDH	CDCP1	406	Q9H5V8
AMKENVQKQWRQHLC	ADGRG6	1116	Q86SQ4
SKEMQASRQWIHVAC	GPR33	191	Q49SQ1
IEIHNSWCEAMKKLR	ARHGEF11	786	O15085
DQPCVKRWSAMHEAA	ASB15	171	Q8WXK1
VWMENSKLKSLEICH	ACOT9	286	Q9Y305
QGTMNRLLTSWHKCK	CALHM1	296	Q8IU99
SKNDEVRKHASWAVM	ARMC3	491	Q5W041
QMSEWALLKRHQCED	DUS3L	346	Q96G46
EKHCRDMEEASQRKW	CDKN1B	46	P46527
NLKTECDLWHLMVKE	DENND3	796	A2RUS2
EDKHSQCKWVMGSIL	TMEM37	116	Q8WXS4
SEQKWMAVKCVHRTQ	ATP2C1	456	P98194
KQVMEHIWKLQEFCN	NR2C2	466	P49116
HIWKLQEFCNSMAKL	NR2C2	471	P49116
AMWRKILQNCHDDAA	PPP2R3B	201	Q9Y5P8
ALNEMWKCQNMLRSH	PDS5A	501	Q29RF7
KVCANHWITTTMNLK	RGPD5	1106	Q99666
KVCANHWITTTMNLK	RGPD8	1106	O14715
ENWLKMLCRHVANTI	ECT2	781	Q9H8V3
LCRDHSSWLQMKQNR	IQCC	116	Q4KMZ1
HRWCSNKKNAAVMDQ	KIR2DS2	266	P43631
KREKWCHMTQEERDD	KIAA0513	336	O60268
HCIELMVKREDSWQK	CERT1	261	Q9Y5P4
HRWCSDKKNAAVMDQ	KIR2DS4	266	P43632
LNCWSMSLDNTMKRH	MDN1	3816	Q9NU22
KSDDRTRVNWCLKHM	MAEL	216	Q96JY0
TRVNWCLKHMAKASE	MAEL	221	Q96JY0
VSCMQRKKVQIHSWD	DCAF4L2	51	Q8NA75
HLWCSNKKNAAVMDQ	KIR3DL1	361	P43629
KLEDRKWHSMASLSC	GRID2	341	O43424
KWHSMASLSCIRKNS	GRID2	346	O43424
DMLQLWCHASEREKK	PNMA6E	346	A0A0J9YXQ4
KDRSCKMWNLVTGQE	KIF21B	1326	O75037
SHRFAKLCMSDKLWE	FBXO36	121	Q8NEA4
NERWVLTAAHCKMNE	KLK7	61	P49862
MNRHLWKSQLCEMVQ	IKBKG	1	Q9Y6K9
LVDINKNLWEKMRHC	KNL1	1971	Q8NG31
HRWCSDKKNASVMDQ	KIR2DS3	266	Q14952
SKHSWRKQIEDQMTR	PARP4	1031	Q9UKK3
HTNKWTLCAQMSKRR	KLHL5	631	Q96PQ7
CRDFLMLAQTHSKKW	OSBP	276	P22059
MKELKQALVNCNWSS	PEF1	136	Q9UBV8
QEEEEKRHCWMKQFK	LRRIQ1	201	Q96JM4
HRWCSNKKNASVMDQ	KIR2DS5	266	Q14953
SNWKERLACMEEFQK	CKAP5	611	Q14008
KWTMISRDNNTKLEH	IGSF10	471	Q6WRI0
KHMICWTSNDGQFKL	ELK4	21	P28324
QCLQEDWERSAAMKK	CCDC81	581	Q6ZN84
HLKFRTTRKWNGCMQ	GPR32P1	176	Q8NGA4
VAECMILANHWVAKK	DIS3L	681	Q8TF46
MGFSCRQKTWHKITD	ADGRF2	131	Q8IZF7
NSKLCLNWEHVKTME	CNTN6	916	Q9UQ52
DMAAQITKRKWEAAH	HLA-A	161	P04439
TKWNKHMMDTRDCQV	KCTD6	161	Q8NC69
RKWHSMASLNCIRKS	GRID1	341	Q9ULK0
KMQDKCREVLAWLEH	HSPA6	571	P17066
RWHQRMSKMSQEICT	GOLGA8R	251	I6L899
RWHQRMSKMSQEICT	GOLGA8O	251	A6NCC3
LHWKLTKRKCETSNM	CHIC1	191	Q5VXU3
HNMWLKCVSLKRNDF	KBTBD6	501	Q86V97
HSLWDVDRKKNMFCS	LGSN	316	Q5TDP6
ATEKSEWMNHINKCV	PLEKHF2	116	Q9H8W4
EWMNHINKCVTDLLS	PLEKHF2	121	Q9H8W4
KVCANHWITTTMNLK	RGPD1	1091	P0DJD0
HRWCSDKKNAAVMDQ	KIR2DS1	266	Q14954
IICWLTKAEHAMQKR	UTRN	2096	P46939
ASEDHTLKMWNLQKT	STRN	481	O43815
LQKMQSLWEKACENH	TRIM49	141	P0CI25
TEMKESKGQQVCRWH	SYT14	536	Q8NB59
WNTPHCMEDTMRKNK	SLC6A6	166	P31641
DWMVPEAHRQNCRKK	SEMA4F	101	O95754
RHCNMVLENVKEMWT	SNRPD2	61	P62316
EEMKETKGQQICRWH	SYT16	626	Q17RD7
RMKWESLHQEFSTKQ	SYNE1	6296	Q8NF91
CSLKQMVHEGNQRWD	SYNE1	8076	Q8NF91
VAMKNLADNHWAKTC	BMT2	76	Q1RMZ1
CEFLKKHDQKWEVNM	TDRD15	1441	B5MCY1
KHDQKWEVNMICDEK	TDRD15	1446	B5MCY1
ISWQYLHCNDEKMQK	TOGARAM2	216	Q6ZUX3
KASDHGWVCDQRVMK	MRM3	301	Q9HC36
FHQLCVDQWLAMSKK	RNF165	316	Q6ZSG1
AMHVLWDLKKNFRCA	SAMD9L	751	Q8IVG5
KIVDIMAKWNRASSC	SLC22A16	306	Q86VW1
RVWQKHTACQRSKGM	POGZ	1211	Q7Z3K3
IHNTAKNKWFVCMAK	PREX1	361	Q8TCU6
MALRCWSLKFKQSDH	MYCBP2	3676	O75592
EVIKSTHQCWKALLM	PPA2	266	Q9H2U2
HDQCEWRCMDKTKLT	IQANK1	346	A8MXQ7
SCIWEMNHNAEILKT	DIS3	561	Q9Y2L1
CQLFEHWKTLMNRQD	ABCC8	921	Q09428
VKWENDMHCAVKIQD	RNF17	961	Q9BXT8
DMHCAVKIQDKNQWR	RNF17	966	Q9BXT8
KMVWDQINHCTLKLR	TRIM67	421	Q6ZTA4
CLEQGKDPWNMKRHS	ZNF738	86	Q8NE65
GKAFCWKSQLIMHQR	ZNF268	926	Q14587
VWNVETKDCMERVKH	WDHD1	256	O75717
LQKMQSLWEKACENH	TRIM49C	141	P0CI26
VTWDCMKTQLSEAVH	TMEM214	651	Q6NUQ4
DWVSMSHITAENCKL	XPO5	236	Q9HAV4
HNTAKNKWFVCMAKT	PREX2	331	Q70Z35
WHFEARKSQILKCME	TSHZ3	376	Q63HK5
ERHMISSWEQKNNCV	TPGS2	46	Q68CL5
SLEHCSALKWLKENM	TOPAZ1	1666	Q8N9V7
SKTQLEKHRIWNHMD	ZNF512B	151	Q96KM6
SLWRKMCENHRNLNM	TRIM51G	146	A0A3B3IT33
WKCKDHTEMLQENQG	ZNF140	121	P52738
LQKMQSLWEKACENH	TRIM49B	141	A6NDI0
LCNESKDEQWKRAMD	PPIP5K2	841	O43314
DAAKFVMRWLCKHEN	ZYG11A	466	Q6WRX3
NNSLHDMKTVVKTWR	TRRAP	2961	Q9Y4A5
RDCAEKVASHWQQLM	TRIO	986	O75962
CNWFHKRMEELNSEK	AGL	371	P35573
RWHQRMSKMSQEICT	GOLGA8N	251	F8WBI6
QCQHWVRLTMKKGTI	HECTD3	276	Q5T447
SQHWCKRTLMDDNKV	NAPEPLD	251	Q6IQ20
WLTGICHNEKNEVMS	GRIN2B	796	Q13224